Medicine guide
Avaglim
·
- Prescription status not stated
- Digestion, stomach, diabetes and nutrition
- Active substance
- Rosiglitazone;glimepiride
- Made by
- SmithKline Beecham Ltd
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- AVAGLIM is indicated in the treatment of type 2 diabetes mellitus patients who are unable to achieve sufficient glycaemic control on optimal dosage of sulphonylurea monotherapy, and for whom metformin is inappropriate because of contraindication or intolerance.
From the official label · 2026-09-30 · European Medicines Agency
Details
| Made by | SmithKline Beecham Ltd |
|---|---|
| Active substance | Rosiglitazone;glimepiride |
| Used in | Digestion, stomach, diabetes and nutrition |
| Classification | A10BD04 · Digestion, stomach, diabetes and nutrition |
| Authorised on | 2006-06-27 |
| Last updated by the regulator | 2011-08-12 |
| EMA product number | EMEA/H/C/000675 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).